Dr. Daniel Cameron

Could Lyme Disease Be Linked to Guillain-Barre Syndrome? Lyme disease Guillain-Barre syndrome may represent an underrecognized association, raising questions about whether infection can trigger immune-mediated neuropathy. In the case study Clinical association: Lyme disease and Guillain-Barre Syndrome, the authors highlight Borrelia burgdorferi as a potential antecedent infection associated with the development of GBS. [1] The […]

Babesia Cases Skyrocket in Wisconsin with 26-Fold Increase Babesia cases Wisconsin have increased significantly over time, with reports showing both rising incidence and geographic expansion. Between 2001 and 2015, Babesia cases in Wisconsin increased 26-fold. “There was a 26-fold increase in the incidence of confirmed babesiosis, in addition to geographic expansion,” according to MMWR. Factors

Fibromyalgia Quality of Life: Challenges Beyond Pain Fibromyalgia quality of life may be significantly affected by chronic pain, fatigue, and cognitive symptoms, contributing to emotional and psychological burden. Clinicians have noted lower levels of gratitude and reduced quality of life among fibromyalgia patients compared with individuals living with other chronic illnesses. Gratitude has been associated

Can Personalized Lyme Care Help Address the Limits of Clinical Guidelines? Personalized Lyme care reflects a broader challenge in medicine: applying standardized guidelines to complex, individual patients. A study published in the Journal of Hospital Medicine found that physicians across specialties often struggle to follow rigid clinical guidelines when treating real-world patients. Doctors Question Guideline-Based

Could Borrelia DNA Persistence Explain Ongoing Lyme Symptoms? Borrelia DNA persistence may help explain why some patients continue to experience symptoms even after standard Lyme disease treatment. In the article “Doctor Says You Are Cured, But You Still Feel the Pain,” Cervantes explores how persistent bacterial DNA may contribute to ongoing illness. This research challenges

Could Low-Dose Naltrexone Help Lyme Disease Patients? Low-dose naltrexone Lyme disease treatment is being explored as a potential way to reduce inflammation and improve symptoms in chronic illness. A pilot study examining low-dose naltrexone (LDN) in fibromyalgia provides insight into how this therapy might affect inflammatory pathways relevant to Lyme disease. In a 10-week, single-blind

One Tick Bite: Multiple Tick-Borne Diseases to Consider Tick-borne diseases one bite is an important concept, as a single tick exposure may transmit more than one infection. Professor Durland Fish, an epidemiologist at Yale School of Public Health, highlights the importance of recognizing multiple infections that can follow a single tick bite. [1] These include:

Lyme Carditis and Complete Heart Block in a 26-Year-Old Man Complete heart block from Lyme disease can deteriorate rapidly even after antibiotics begin. A 26-year-old man progressed from 2:1 AV block to complete block with asystole within 24 hours of starting treatment, requiring emergency pacemaker placement. His complete recovery and pacemaker removal after 19 days

Atypical Early Disseminated Lyme Disease Symptoms Early disseminated Lyme disease symptoms may present without the classic rash, making diagnosis more challenging. “On presentation to our hospital, the patient continued to complain of severe headaches and was noted to have mild unilateral right-sided facial droop and a diffuse macular rash throughout the body,” explains Kantamaneni in